Related references
Note: Only part of the references are listed.Duplex value of caveolin-1 in non-small cell lung cancer: a meta analysis
Dali Chen et al.
FAMILIAL CANCER (2014)
Caveolin-1 promotes an invasive phenotype and predicts poor prognosis in large cell lung carcinoma
Fei Han et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells
Yong Weon Yi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Identification of Biological Properties of Intralymphatic Tumor Related to the Development of Lymph Node Metastasis in Lung Adenocarcinoma
Keisuke Kirita et al.
PLOS ONE (2013)
Caveolin-1 Increases Aerobic Glycolysis in Colorectal Cancers by Stimulating HMGA1-Mediated GLUT3 Transcription
Tae-Kyu Ha et al.
CANCER RESEARCH (2012)
Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of STAT3 signaling
Fabia Pancotti et al.
CELLULAR SIGNALLING (2012)
Cigarette Smoke Induces Aberrant EGF Receptor Activation That Mediates Lung Cancer Development and Resistance to Tyrosine Kinase Inhibitors
Simone Filosto et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Susanna V. Ulahannan et al.
CANCER INVESTIGATION (2011)
Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors (Publication with Expression of Concern. See vol. 14, 2019) (Publication with Expression of Concern. See vol. 14, 2019)
Floriana Morgillo et al.
PLOS ONE (2011)
Filamin A Modulates Kinase Activation and Intracellular Trafficking of Epidermal Growth Factor Receptors in Human Melanoma Cells
Jennifer L. Fiori et al.
ENDOCRINOLOGY (2009)
Caveolin-1 expression in lung carcinoma varies according to tumour histotype and is acquired de novo in brain metastases
Paola Cassoni et al.
HISTOPATHOLOGY (2009)
Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor
Beatriz E. Rendon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Downregulation of caveolin-1 affects bleomycin-induced growth arrest and cellular senescence in A549 cells
Annett Linge et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas
M Taron et al.
CLINICAL CANCER RESEARCH (2005)
Caveolin-1 in oncogenic transformation, cancer, and metastasis
TM Williams et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma
A Horiguchi et al.
JOURNAL OF UROLOGY (2004)
Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma
T Kato et al.
CANCER LETTERS (2004)
Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation
A Fong et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Regulation of map kinase signaling modules by scaffold proteins in mammals
DK Morrison et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2003)
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene
WC Kai et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation
B Razani et al.
BIOCHEMISTRY (2000)